A leather and brass dog collar once owned by Charles Dickens is one of a number of items coming under the hammer at a sale of 'dog art' at Bonhams New York on 16th February.
You'll have to have deep pockets, though: with a nameplate inscribed 'C. Dickens, Esqe,, Gad's Hill, Place, Higham.' the collar carries an estimate of $4,000 - $6,000.
If you're feeling really flush, you could also pick up a painting by the foremost dog artist John Emms. Amongst the six Emms lots to be offered, a painting titled The Bitchpack of the Meath Foxhounds is expected to fetch $500,000 to $700,000.
The illustrated auction catalogue for the sale is online and available to view at: http://www.bonhams.com/dogs
European veterinary practitioners are to receive guidance on the appropriate use of the fluoroquinolone group of antibiotics in treating a wide range of common diseases in companion animals.
The advice has been drawn up by the REQUEST team, a multinational and multidisciplinary group of experts which met for the third time last November. Their recommendations have been designed to help ensure the continued availability of this class of antibiotics in both veterinary and human medicine.
The REQUEST initiative aims to achieve a consensus on when and how to prescribe fluoroquinolones, based on a detailed assessment of published scientific data by its panel of nine acknowledged international experts. Following earlier meetings in Lyon and Vienna they have reached a stage in this ongoing project in which they can offer specific guidance on the use of fluoroquinolones in treating three important conditions in dogs: pyoderma, bacterial diseases of the upper respiratory tract and lower urinary tract infections. They will also be offering guidance on the appropriate use of this class of antibiotics in cats to avoid the development of retinal toxicities, which may occasionally result from treatment with one particular fluoroquinolone drug, enrofloxacin.
The guidance will be presented in papers to be submitted to those scientific journals which will be easily accessible to veterinary practitioners throughout Europe. Further papers will be produced and translated into the main European languages giving guidance on fluoroquinolones use in other important bacterial conditions in dogs and cats.
In the later stages of the project, the team will be highlighting priorities for future research and will use its influence to encourage collaborative studies involving the animal health industry, practitioners, veterinary schools and other research institutions, which will validate and redefine the current recommendations. They will also advise on studies which may provide the information needed in those clinical areas where there is currently insufficient published data on which to base any practical advice, such as the use of fluoroquinolones in minor companion animal species.
The REQUEST initiative is supported by Vetoquinol, a global supplier of fluoroquinolone medicines to the veterinary community. Further support is provided by the healthcare consultancy StratAdviser Ltd, which gives assistance on methodology and other scientific matters and also guarantees the independence of the expert group.
Denmark-based consulting firm praQtice has launched a subsidiary in the UK to offer veterinary practice management consultancy services. The company says it concentrates on six business areas: strategy and business development, marketing, employee and manager development, finance, research and analysis, and training. praQtice says it has worked with a wide range of practices, from the small local practice to the large hospital, helping them bring together their mission and vision. The company also has the benefit of having an in-house marketing and communication department which it says has had considerable success - not only in Scandinavia, but in the UK when last year praQtice won a Veterinary Marketing Association award. The launch in the UK will primarily be driven by three praQtice consultants - founder and business developer Christian Kolthoff, Marketing Consultant Mario Riewerts and Business Developer Helen Kington.
Helen said: "This will be great for UK vets, largely it has been the same group of consultants working with the same thoughts and ideas for the last 10 years. We need to look beyond our borders in order to evolve. In Scandinavia you can only put a mark up of 5% on your drugs, which does not make you a profit. Thus they have learnt to be much better in delivering and pricing for their professional service, I am sure we can learn a lot from them. What we also see all over Europe is that practices are getting bigger and bigger. But as the practices grow, so does the number of problems and the partner's income rarely follows. praQtice is about quality of life and allowing yourself to dream, we then give you the tools along with helping you through the implementation to make those dreams and ambitions come true.
You can meet the team at the VPMA Congress in Oxford (28th-30th January), where founder and CEO Christian Kolthoff will be speaking. Meantime, if you would like more information about praQtice, visit www.praqtice.co.uk or telephone Helen Kington on 07765 338 607
Dorwest Herbs has highlighted research that suggests a highly rational mode of action for kelp seaweed as an aid in the treatment of obesity when used alongside a weight reduction diet. The company is asking vets and nurses to look at the evidence and consider using licensed herbal medicines to help cats and dogs lose weight naturally. To help you evaluate the product, Dorwest is giving away 50 trial packs of Kelp Seaweed Tablets.
Mary Boughton MBE, Quality Director at Dorwest Herbs and the UK's leading specialist in the formulation of veterinary herbal medicines said: "We have lots of evidence that Kelp Seaweed Tablets work as an aid in the treatment of obesity but traditional explanations were based on the effect of iodine supplementation on thyroid function as a mode of action. That just didn't hold water for us. However, in common with many conventional medicines, the mechanisms for mode of action of herbal medicines are often not known. So, it was with some excitement that we heard of research that demonstrated that fucoxanthin, a pigment found in kelp, upregulates expression of UCP1 (uncoupling protein) and produces weight loss in the same region as conventional anti-obesity drugs."
Various studies estimate pet obesity may affect 30 to 60 per cent of pets in the UK and arthritis, heart disease and diabetes are just some of the diseases that occur with increasing frequency in obese pets. The research indicates that fucoxanthin has an effect on glucose metabolism and may lower the risk of coronary heart disease in humans. Phlorotannins found in brown seaweed have also recently been indentified as interfering with both the onset and consequences of osteoarthritis. Mary Boughton points out that multiple effects are often seen when herbal treatments are used, "Herbal treatments contain thousands of plant derived chemical compounds and are known for their diverse action, as opposed to the 'magic bullet' effect seen with conventional medicines. In a condition such as obesity where we see many disruptions of normal metabolism and several co-morbid conditions, choosing a herbal treatment makes sense. Kelp Seaweed Tablets are the logical alternative."
Dorwest has prepared a fully referenced technical information sheet detailing recent scientific studies and data from herbal formularies with reference to the role of kelp seaweed in obesity management.
To help vets and nurses further evaluate Kelp Seaweed Tablets - a licensed herbal medicine - used as part of a weight management programme the company is giving away 50 FREE trial packs containing seven weeks of Kelp Seaweed Tablets for a large breed dog, a case report sheet and the technical information sheet. There is also a prize of £100 of John Lewis shopping vouchers for the most informative case report received before the end of February 2010. There is one pack available per practice, while stocks last.
To request a technical information sheet or pack call Dorwest Herbs on 01308 897272.
Genitrix is offering a free poster-sized treatment and dispensing guide for small animals. Designed to be pinned on the consulting room or dispensary wall, the poster sets out key data, including active ingredients, species information and application advice for the company's range of anti-parasite treatments for rabbits, ferrets, rodents, reptiles, birds and other exotic pets.
These include the ivermectin-based Xeno topical spot-on and spray range; Xenex Ultra, the permethrin-based topical spot-on preventive treatment for flystrike; Lapizole, a fenbendazole-based oral treatment for E.cuniculi and Mycozole, a miconazole-based spray for fungal infections, including ringworm.
Rob Watkins, Marketing Director at Genitrix, said: "The treatment guide provides easy to use and clear information on all our small animal products and their use for the practice team."
To request a free poster, please contact Genitrix on 01403 786345 or by email to mail@genitrix.co.uk
The University of Glasgow Small Animal Hospital has completed a £15 million pound development, including the installation of state-of-the-art diagnostic imaging equipment from Siemens Healthcare.
A Magnetom Essenza MRI, a Somatom Spirit CT and Multix Top analogue X-ray are now in place to assist the examination of animals and to diagnose conditions quickly and accurately. A further order for an Oncor Impression linear accelerator has been placed to enable the hospital to provide cost effective and flexible radiotherapy for its animal patients.
The Essenza 1.5T MRI scanner replaces a visiting mobile MRI to provide onsite imaging. According to Siemens, the Essenza is able to give a high level of diagnostic information in just one examination. With rapid and high quality imaging, animal patients spend less time under anaesthetic and the time taken to begin treatment can be reduced.
The installation of the Somatom Spirit CT scanner allows the hospital to look beyond bone structure and into soft tissue and organ imaging. Siemens says the speed and versatility of the Spirit are ideal for veterinary CT. Alongside the Spirit, the hospital has also installed a Multix Top analogue X-ray system providing the hospital with a simple and efficient imaging tool.
Calum Paterson, Hospital Manager at Glasgow Small Animal Hospital said: "By advancing our scanning facilities we are able to increase the services we offer and provide rapid, high-resolution images for our patients. The Siemens scanners are highly suitable in terms of their size and design to be able to accommodate all the small animal patients we see."
James Weir, Regional Sales Manager at Siemens Healthcare said: "Siemens technology is designed to speed up diagnosis by providing faster examination times and high quality imaging. These key functions provide excellent quality of care to any patient, be it human or animal. The installations are transforming veterinary care by providing enhanced diagnosis and improving treatment pathways for domestic pets."
A Dogs Trust Glasgow resident who made the news last January for being so obese he could not even walk has lost almost half his body weight.
Patch, a six year old Beagle Cross, weighed the same as an average six year old child - 4.5 stones (28.45kg) - when he was brought to the Rehoming Centre last year.
Staff desperately hoped 2009 would see him find a new home and see him shed almost half his bodyweight to reach his goal of 2.4 stone (15kg). After finding a new home with the MacLean family in Motherwell, exactly one year after hitting the headlines Patch is within sniffing distance of his target by weighing in at 2.9 stone (18kg).
Vets had warned that a rapid weight loss would put strain on Patch's organs and could actually harm him, so it has been a slow, careful process. He follows a strict diet and his exercise levels have been built up gradually, with careful monitoring by veterinary staff.
Claire Kelman, Dogs Trust Glasgow Assistant Centre Manager, said: "When Patch first came to us he was so obese he couldn't even walk and needed a sling to be moved from one place to another. Now he's lost the weight he can run around and properly enjoy his walks like any other dog.
It just goes to show a good diet and careful exercise can make a real impact, so maybe he can be a shining example for everyone feeling a bit bloated after the Christmas break!"
Images courtesy Centre Press Agency
Janssen Animal Health has announced that it has acquired the distribution rights for a range of sedatives and anaesthetics for small and large animals, including Dexdomitor, Domitor and Antisedan.
Janssen aquired the marketing and distribution rights, which were previously held by Pfizer Inc, from Orion Corporation.
Dr. Enno Gottschalk , Janssen's European Director Marketing and Sales said: "This acquisition of distribution rights results in the perfect combination of proven and effective products with the outstanding service and technical selling capabilities of Janssen Animal Health. The products include the sedative Dexdomitor and Domitor, as well as the antagonist Antisedan. Among large animals, predominantly horses, the sedative injection Domosedan is now on offer as part of the Janssen Animal Health portfolio."
The Kennel Club has broadly welcomed Professor Sir Patrick Bateson's 'Independent Inquiry into Dog Breeding', which has recommended that steps be taken to tackle irresponsible breeders and to change the way the public think about buying dogs.
The Kennel Club, which commissioned and funded the report in conjunction with Dogs Trust, welcomes the report's focus on irresponsible breeders who farm puppies with little concern for their welfare and those who sell poorly socialised puppies on to owners to use as 'status dogs' or as fighting weapons.
The Kennel Club agrees that additional training and support needs to be given to local authorities, which are responsible for issuing breeding licences to those people who breed five or more litters of puppies in a single year, as the current provisions are deemed to be ineffective. It agrees that compulsory microchipping of dogs and increased public education to stop people falling prey to puppy farmers and to help them find responsible breeders are necessary.
It is also glad that the report recognises the need for a 'robustly policed and well respected quality assurance scheme', consisting of breeders that buyers can trust to look after their puppies' health and welfare, and that it suggests that the Kennel Club's Accredited Breeder Scheme, with some modification could be used.
However, the Kennel Club is concerned that the report could have gone further and that its recommendations do not appear directly to cover those breeders who breed less than five litters per year and who are not part of the Kennel Club Accredited Breeder Scheme. The Kennel Club would have liked to have seen a recommendation for regulation to ensure that these breeders follow higher standards, such as compulsory health testing.
Caroline Kisko, Kennel Club spokesperson, said: "Whilst the report recognises that the majority of breeders are responsible, there are those whose actions are bringing the rest of the dog breeding community into disrepute and this needs to be stopped.
"We are glad that the report recognises that the Kennel Club has made a good start in its efforts to unite responsible breeders within its Accredited Breeder Scheme, for the benefit of puppies and puppy buyers, and we believe that this should be the basis for moving forward. We are currently working towards UKAS accreditation of the scheme as suggested by Professor Bateson.
"We agree that responsible breeders should be rewarded and believe that the show ring is the best forum for this. The report recognises that 'dog showing and judging are a powerful lever for change' and the Kennel Club is dedicated to ensuring that only the healthiest dogs are rewarded at shows.
"Public education is vital and all dog welfare organisations must continue to work together to ensure that people know what to look for when buying a dog."
The report looks at genetic diversity in breeds and recognises that the Kennel Club has banned close matings. It advises that future decisions about matings that could affect genetic diversity should be 'breed specific' and made upon evidence based scientific information and advice. To this end it is recommended that the veterinary profession should gather data to show the prevalence of certain diseases and that an advisory council should develop evidence based breeding strategies.
Mrs Kisko continued: "The Kennel Club has long recognised that genetic diversity plays a crucial role in safeguarding the health of dogs and the report is absolutely right to suggest that there are no further blanket rules in place but that decisions are based upon scientific knowledge and are made on a breed by breed basis. This is why we are well on the way to creating a new database which will revolutionise the way that we record dog health data. The data will enable us to bring out our Mate Select programme, which will help breeders to find suitable mating pairs which are most likely to produce healthy offspring. The database will go further than the report's recommendation, as the data will be attributable to specific dogs, rather than being anonymous, and will give us a better picture of the health of pedigrees and crossbreeds. Such knowledge is critical and will enable us to provide information to breeders, vets, geneticists and ultimately the puppy buyer.
"We are keen to harness as much knowledge as possible for the benefit of dogs so we welcome the principle of an advisory council whose members will work with the Kennel Club to advise on decisions about breeding and health. A structure already exists in the form of the Kennel Club's Dog Health Group with its recently extended remit. Additional independent experts include canine and human geneticists, veterinary surgeons and an epidemiologist. Using this framework for establishing the advisory council under an independent chairman would save significant sums of money, which can instead be devoted entirely to the dog health research that the report identified as being in 'urgent' need of more funding."
The Kennel Club and Dogs Trust will now arrange a meeting between all relevant parties in order to move forward with the recommendations from all three reports.
The full report may be downloaded at www.dogbreedinginquiry.com
A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
The University of Edinburgh and the Royal Veterinary College (RVC) have announced a new initiative to help vet students prepare for their Extra Mural Studies (EMS) placements.
Freda Andrews, RCVS Head of Education said: "This is a free online learning tool which will look familiar to any veterinary student who has recently taken the driving theory test. Any veterinary student can use it as part of their preparation for EMS."
The project was drawn up by Dr Catriona Bell at the University of Edinburgh, and Dr Sarah Baillie at the RVC, two lecturers with experience of practice life who want to make sure that student placements work well for all concerned. The aim is that by helping veterinary students understand what will be expected of them, students can be better prepared and get the most out of their placements.
Sarah Baillie said: "We found that students aren't always aware that doing some simple practical things can make a huge difference to how well their placement goes. There are some common pitfalls, such as not taking a lunch with them so the vet has to find a shop whilst out on call, which can catch out the unwary."
Catriona Bell said that the importance of body language was a consistent theme in the research they undertook for the project: "Students want to do well, however placements are a new environment and can be tiring. Vets are not paid to provide EMS, and say they take on students as they want to support the next generation of vets. Students need to make sure they convey their interest and enthusiasm to all members of the practice team through their body language - they don't always realise, for example, what an impact slouching and looking down at the floor can have."
Other tips for students that came out of the research include making sure that you prepare thoroughly before you go, and offering to help out the veterinary nurses.
Sarah said: "We put in what real students told us they'd wished they'd known. The practising vets who support students also gave us valuable information; for example, by explaining what they expect with regards to confidentiality and professionalism, a working vet's skills."
There is no need for a sign-up for students to use the EMS Driving Licence, and veterinary practices who will be hosting EMS students may also find it useful. To try it out for yourself visit www.vet.ed.ac.uk/ems_driving_licence/
A new injectable antibiotic with nil-milk-withhold licensed to treat foul-in-the-foot in a single shot has been launched by Pfizer Animal Health.
Naxcel Cattle's active ingredient is ceftiofur in a patented sustained-release formulation. According to the company, one injection provides a full course of antibiotic therapy, giving seven days of therapeutic blood levels against the majority of inter-digital necrobacillosis ('foul-in-the-foot') pathogens.
Pfizer vet Dave Gilbert says the expectation is that Naxcel Cattle will make on-farm therapy easier and help improve treatment compliance and thereby first treatment success rates, compared to treatments which require repeat injections. "Having the full course in a single injection simplifies treatment protocols and eliminates a number of reasons for non-completion of treatment, such as forgetting a second or third dose, or not giving them because of apparent symptomatic recovery from the condition."
The site of injection for Naxcel Cattle is the subcutaneous area at the base of the ear (see Figures 1 & 2). Injection instructions are supplied in the product pack. Dave Gilbert suggests that provided cattle are adequately restrained during administration the injection technique is simple and straightforward. The dose rate is 1ml/30kg body weight and up to 30ml can safely be given into each site.
Figure 1. Subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).Figure 2. Injection location for the subcutaneous administration of Naxcel Cattle at the posterior aspect of the ear where it attaches to the head (base of ear).
Virbac has announced the reintroduction of chews as part of its dental range.
VeggieDent chews are available in packs of 15 in sizes suitable for small, medium and large dogs. The chews contain chlorhexidine and have a texture and shape designed to optimise plaque removal by physically abrading the tooth surface during chewing.
Product manager Chris Geddes said: "The gold standard of dental hygiene is regular brushing, but that isn't always possible, and products such as this are ideal for those difficult cases."
For further information please speak to your Virbac representative, phone 01359 243243 or email admin@virbac.co.uk.
A survey by Hill's Pet Nutrition has concluded that nine out of ten vet professionals believe UK pets are at serious risk of diet related diseases, mirroring the trends seen in human health, and the recession has increased the risk.
The study of more than 100 veterinary professionals suggests their daily case loads are weighed down with a host of serious man-made dietary-related problems including obesity, diabetes, heart disease and high blood pressure, simply because owners are not feeding their pets appropriately. These problems are on the increase as a result of owners switching to lower quality food or feeding a man-made diet of crisps and chocolate.
Pet Obesity Task Force Committee Member and Veterinary Nutritionist, Dr Daniel Chan, DVM, DACVECC, DACVN, MRCVS said: "As a nation, our modern lifestyles of fast food, large food portions, and too little exercise are taking a toll on our health, our children's health, and now our pet's health. Excessive calories and lack of physical activity are leading to alarming rates of obesity, which has become the most common form of malnutrition in pets today. As the links between obesity and disease are becoming clearer, it is vital that pet owners adopt healthier practices such as feeding appropriate portions of food, avoiding too many snacks and treats, and exercise with their pets."
Despite obesity being the most physically obvious diet-related disease in the UK, the vet professionals who participated in the study agreed unanimously that owners do not realise their much-loved but overweight pet is actually suffering from malnutrition.
The vet professionals were also in agreement that not all pet foods are the same, believing to some degree you get what you pay for. Yet worryingly, 83% of vet professionals believe our pet's health has been another casualty of the economic downturn, as cutbacks in the family budget saw trading-down on pet food. Vets suggest the effects of these cutbacks will lead to increases in cases of diet related diseases in the next two years, with a surge in potentially fatal conditions such as diabetes (61%), intestinal problems and pancreatitis (66%).
Adrian Pratt BVSc MRCVS, Hill s Pet Nutrition Veterinary Affairs Manager, said: The results make sombre reading. Almost all (98%) of the vet professionals who participated report seeing a host of preventable diseases in practice which are the result of inappropriate feeding. While obesity tends to be caused by an excess of empty calories and too little exercise, inadequate nutrients or excess nutrients like salt, will also affect a pet s general health and wellbeing, leading to sickness or long-term diet-related diseases.
Other findings of the study included:
Vets and farmers must do more to improve dairy cow welfare in the UK, according to the British Veterinary Association (BVA). The call comes after careful consideration of major reports and opinions on the welfare of dairy cattle by FAWC (Farm Animal Welfare Council) and EFSA (European Food Safety Authority).
In a new policy statement, released last week, the BVA outlined the need for veterinary surgeons to take an active role in educating farmers and promoting better welfare, as well as working with farming clients towards a 'Herd Welfare Plan' that can be followed alongside the 'Farm Health Plan'.
The BVA says it recognises that some improvements have been made in certain welfare areas, such as longevity, but that issues relating to lameness, mastitis, housing and infectious diseases, such as TB, continue to be of concern.
Veterinary surgeons are well placed to offer help and advice in order to educate farmers on welfare aspects and how they affect herd health, productivity and ultimately, profit.
The policy also addresses issues around breeding for certain traits, which should always be discussed with a vet through a breeding plan, and the challenges of housing dairy herds. The BVA believes much can be done to achieve high welfare standards through good housing.
Finally, the BVA supports retailers who reward farmers financially for improving welfare standards for dairy cows and their calves.
Professor Bill Reilly, President of the BVA, said: "Recent reports have highlighted a number of major concerns about the welfare of dairy cows and their calves, and the BVA feels strongly that vets can take a leading role in addressing these issues.
"Lameness, mastitis, inadequate housing and infectious disease can all lead to poor welfare. Not only is this unacceptable for the animals, but it can be bad for the farmer's business.
"By working together, vets and farmers can and should do more to improve dairy cow welfare through Herd Welfare Plans, breeding plans and improved housing conditions."
Keith Cutler, President of the British Cattle Veterinary Association (BCVA), added: "While the UK enjoys higher standards of dairy cow welfare than many other countries, there are still some issues that need to be tackled.
"Vets and farmers need to work together to address problems. In my experience most farmers are pleased to discuss issues with their vets and then work in conjunction to improve the health and welfare, and ultimately the productivity and profitability, of their herds."
Hill's has launched Science Plan Snacks: a new range of treats which includes light, immunity support, healthy mobility, oral care and skin & coat variants for adults, and immunity support and skin & coat variants for puppies.
Market research has shown that 76% of UK dog owners feed their pet treats, and that snacks represent 33% of total market value in the dog food segment. Hill's has identified that 84% of pet owners want their pet's snack to be healthy and 67% want the snack to meet a specific need. However, the company says many pet snacks and table scraps are high in salt, sugar and fat and overfeeding can unbalance a nutritionally balanced diet provided by the main meal, as well as being a major cause of obesity.
Adrian Pratt, Veterinary Affairs Manager at Hill's said: "Owners like to treat their pets to snacks as it helps cement their close bond but they are also aware that feeding unhealthy food is a bad idea. We believe that responsible snacking is the way forward and to that end have launched Science Plan Snacks. The range is not only low in calories and made with all the optimal nutrition principles that guides the formulation of Science Plan main meal but also features on-pack guidelines to indicate the number of snacks that can be given per day. "
Hill's says the new range outperforms other mainstream biscuit treats in taste tests, being up to 79% preferred. Science Plan Snacks offer fatty acid ratios and blends to support healthy mobility and patented fibre technology in the oral product, with controlled levels of calcium and salt. The resealable bag maintains freshness and the high impact premium black packaging provides great stand out on shelf.
For further information contact your Hill's Territory Manager or Hill's customer service on 0800 282438.
Eight vet students have been recognised for their exceptional work with the Intervet / Schering-Plough Animal Health Connect Bursary Awards, designed to provide financial assistance for students for elective research during their college years. Three main awards were made for projects focussing on laterality in dogs, stallion semen preservation, and developing a better understanding of wobbler syndrome in horses.
Charlotte Cockburn from the Royal Veterinary College (RVC) and Hayley Harwood from the Royal Dick School of Veterinary Studies (Edinburgh) were the joint winners of the main Bursary Award, while the RVC's Holly Claridge was presented with the inaugural Equine Award.
Charlotte's research investigated tests for laterality in dogs to determine if domestic dogs show a significant paw preference and to identify a test that can be used for this purpose by veterinary practices. The results showed a lateralisation bias in the dog population towards the left with no significant correlations between paw preference and the sex, age or breed of dog. In addition, the initiation of gait test used in the study was the only test that gained a response from 100% of the dogs.
Hayley set out to investigate the motility of stallion spermatozoa thawed at various rates and maintained for up to 24 hours with the aim of designing a protocol for the thawing of semen that would allow cooled transported frozen-thawed semen to be used effectively. The study showed that for total motility, thawing the straws at 72°C resulted in significantly higher motility than when compared with other treatments.
Holly's research aimed to describe the 3D anatomy of the cervical articular process joints in relation to the spinal cord and whether artificial distension of these joints, mimicking effusion, would cause the pouches of the joints to compress the spinal cord in the horse. The study concluded that in the absence of any other soft tissue or bony changes effusion of these joints is unlikely to cause spinal cord compression. However, given that these joints and the spinal cord are in close approximation, in the presence of other changes, an effusion may have the potential to cause compression.
While Charlotte, Hayley and Holly were the overall winners, five other students also received a Connect Bursary from Intervet / Schering-Plough Animal Health to fund their research. The Bursaries were awarded to Rebecca Johnson and Sharon Brown (Glasgow), Gabrielle Laing (Liverpool), Alex Torrance (Cambridge) and Amy Gordan (Bristol). Students were required to present their work to a judging panel from Intervet / Schering-Plough Animal Health, representatives from the veterinary schools and industry key opinion leaders. Two further Bursaries were also awarded to students from Nottingham.
David Hallas, General Manager at Intervet / Schering-Plough Animal Health said: "Being part of the Connect Bursary is intended to give veterinary students both the freedom to explore new ground as well as providing a taste of working in industry. The fact that we awarded a record number of Bursaries this year, elected joint winners and launched the new Equine Award is testament to the refreshingly high standard of work being undertaken by veterinary undergraduates."
Scientists from the Institute for Animal Health, Pirbright, UK Met Office and the Jersey State Veterinary Service and Jersey Meteorological Department, are working together on an early-warning system to help defend cattle against the spread of 'bluetongue' disease, according to a study published today in Weather.
The team is fusing meteorological data with ecological information to anticipate when disease carrying midges are likely to be carried on the wind from the continent to the UK and Channel Islands.
Lead author Dr Christopher J. Sanders from the Institute for Animal Health said: "The bluetongue virus, BTV, represents a major and unprecedented epidemic which has spread across Western Europe since 2006. While accurate estimates of costs incurred are not yet available, it is estimated that these could be in the order of many tens of millions of pounds."
BTV is carried by small biting midges, Culicoides, one of the smallest species of biting flies found on livestock. One bite from a midge fully infected with BTV can be enough to lead to infection in cattle and sheep, which can be fatal.
Since 1998 the range of the African species of biting midge has expanded from the Mediterranean basin resulting in an overlap with the range of European species. This enabled European species of midge to pick up virus from infected animals for the first time and go on to transmit it in Southern Europe. However, the arrival of BTV in northern Europe in 2006 was independent of this northwards movement of BTV, jumping north rather than from a gradual spread, and was reliant on transmission only by European midges common and widespread in the area.
In 2006 the disease was found in Belgium, France, the Netherlands, Luxembourg and Germany; 700 km north of previous European outbreaks. In June 2007 the disease was once again reported in Germany and by October 2008 24,000 cases were reported in France alone. In September 2007, the first cases of BTV were discovered in the UK, where fortunately the outbreak was small.
The danger that the disease may again spread to the UK from across the channel is of special concern to the Channel Island of Jersey, which maintains a world renowned cattle industry, but is at heightened risk of infection if the disease becomes established along the Cherbourg peninsula or the Normandy and Brittany coastline.
The risk comes from the possibility that the tiny midges can be carried on the wind from the French coast to the Island. To monitor this threat the team set up midge light traps in farms across the island to monitor midge activity and to identify the presence of any potential vector species.
The results were then collated and analysed alongside data from the Jersey Meteorological Department, which allowed the team to pinpoint when livestock were at risk from a number of locations on the mainland. This information was fed into the UK Met Office early-warning website which has also been used on the mainland to help predict and defend against the disease.
"Environmental conditions, especially temperature, wind speed and direction have a significant impact on the biting midge in terms of activity and abundance," concluded Sanders. "Monitoring the midge population in Jersey will provide the farming community on the mainland with knowledge of when the midge season commences in the diseased areas of the near continent."
Research amongst veterinary surgeons by Janssen Animal Health, maker of Cavalesse oral and Cavalesse topical, has revealed that owners could be doing more harm than good when it comes to managing sweet itch in their horses.
92% of vets questioned are aware that people follow old wives' tales by administering lotions and potions such as garlic and olive oil to ward off flies during the summer sweet itch season, when garlic actually has the opposite effect of attracting them.
According to Janssen, it is thought that only a quarter of horse owners are aware that it is important to carry out preventative measures before the start of the midge season to help alleviate sweet itch. 14% of people are thought to go to their vet for advice on sweet itch, while 30% seek help from their country store or tack shop, 27% search for information on websites and 26% ask other horse owners for guidance. This is despite the fact that 92% of those questioned believe that sweet itch would clear up quicker if people sought advice from their veterinary surgeon.
Nicki Glen, marketing manager at Janssen Animal Health said: "Sweet itch can be an incredibly difficult and frustrating condition to manage, however horse owners do not tend to seek advice from their vets. It is therefore important to educate horse owners while you are on yard visits with pro-active advice on the condition for the long-term health and welfare of horses."
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. Janssen says the supplement helps horses maintain a healthy skin and promotes normal immune function in horses prone to summer allergies.
Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
For further information on Cavalesse and Cavalesse Topical please contact your Janssen Animal Health account manager or phone 01494 567555.
A new publication into the benefits of spironolactone (Prilactone - CEVA Animal Health) has supported its use as part of first-line therapy for the treatment of dogs with congestive heart failure caused by mitral heart disease, according to CEVA.
The double-blind placebo-controlled study1 involved 212 dogs on either spironolactone or a placebo, in addition to conventional therapy including an ACE inhibitor and furosemide. It revealed that over a 15 month period 25.5% of dogs either died, were euthanased or severely worsened in the placebo group compared to 10.8% in the spironolactone group. This represents a 55% reduction in the risk of cardiac morbidity-mortality and a 69% reduction in the risk of cardiac-related death or euthanasia.
Further research2 has also revealed that aldosterone antagonists, such as spironolactone, help to prevent myocardial fibrosis, a pathogenic process involved in the progression of heart failure.
For more information, 'Start Conversation' with Fraser Broadfoot MRCVS at CEVA Animal Health, or ring 01494 781510.
1 Efficacy of spironolactone on survival in dogs with naturally-occurring mitral regurgitation caused by myxomatous mitral value disease. Bernay F, Bland JM, Häggstrőm J, Baduel L, Combes B, Lopez A, Kaltsatos, V. (2010). Journal of Veterinary Internal Medicine.2 Aldosterone receptor antagonists - how cardiovascular actions may explain their beneficial effects in heart failure. Ovaert P, Elliot J, Bernay F, Guillot E, Bardon T. (2010). Journal of Veterinary Pharmacology and Therapeutics.
MDC Exports has launched a new Soft E Collar specifically designed to help greyhounds recover, post-op.
MDC says the new Soft E Collar has been designed to take into account a greyhound's long fragile neck and to make wearing a medical collar much more comfortable. It also features a drawstring design to prevent the animal from being able to back out of the collar, something the company says is a particular problem when greyhounds wear conventional collars.
According to MDC, the Soft E Collar acts as an effective barrier to a treatment area while ensuring an animal can eat, drink and sleep comfortably. It allows free movement of the head, neck and body so the animal can carry on as normal. And unlike traditional "Elizabethan" collars, the Soft E Collar is made out of soft fabric that is non-allergenic, non-toxic and water repellent. It is tough and easily able to withstand persistent clawing and chewing. Lastly, it is lightweight and very flexible, folding flat for ease of storage and springing back to its original shape when you are ready to use it.
The Soft E Collar for greyhounds is priced from £7.95. For more information visit http://www.mdcexports.co.uk/
150 graduates will get the opportunity to work in knowledge intensive companies across London and the south east following the announcement today that a joint bid by UCL and the Royal Veterinary College (RVC) has been awarded £240,000 of Government funding as part of a national scheme designed at helping young people into work.
UCL will administer some 115 internships in the digital industries, advanced manufacturing, engineering and financial services, while the RVC will deliver around 35 life science internship placements. In line with all of the HEFCE-supported work experience schemes, places on the UCL-RVC will be available to graduates of all universities, with priority being given to those that graduated last year and have yet to find stable employment and for those graduating in 2010.
The paid internship placements will help recent graduates to develop vital employability skills, through both work based learning and skills training sessions, and allow both small and large companies to preserve novel research, development and commercial projects during the economic downturn.
The award will help both institutions to build on their existing programmes. UCL already planned to offer 50 work experience places this summer following from their successful scheme, first run last year. The grant similarly allows RVC and The London BioScience Innovation Centre to continue to grow its reputation as an employer by helping life science graduates make the transition from higher education to the commercial bioscience sector through work experience placements and skills development.
Jim Gazzard, Enterprise and Technology Executive at the RVC said: "Recent graduates have much to offer knowledge intensive companies. In our experience these companies are looking to recruit talented graduates but are restricted in their ability to do so in the current economic climate. Graduate internship schemes help to solve this problem, allowing companies to continue to explore exciting commercial projects and graduates to gain a foothold in the job market while developing essential employability skills."
To date the RVC has received over 1,000 applications for 60 internship placements on its ORBIS internship scheme. This shows the significant demand from graduates seeking careers in leading bioscience and bio-veterinary companies.
The Department for Environment Food and Rural affairs has marked the 10th anniversary of the Pet Travel Scheme with the release of some interesting facts and figures...
The scheme started on 28 February 2000 when owners were first able to travel to and from the UK without placing their pets in quarantine, as long as they fulfilled certain important disease control criteria.
A pug called Frodo Baggins was the first animal to travel with a pet passport and since then, 660,000 pet journeys have been made using pet passports.
60 per cent of the pets that have travelled under the scheme belong to UK owners. Animals from Ireland, France, Germany, Belgium and the Netherlands make up about another 20 per cent.
According to Defra, the scheme was set up in response to growing demand from owners to travel with their pets, and the declining risk of disease allowed these changes to be made. In 2004 the European Union followed the UK's lead and introduced a similar system for all Member States which has also proved very successful.
Defra says the success of the scheme is fully demonstrated by the fact that it has not been associated with a single case of rabies. Animal Welfare Minister Jim Fitzpatrick said: "The Pet Travel Scheme was set up to enable British animal owners to enjoy travelling with their pets when they need to. The success of the scheme shows that responsible pet ownership makes a large contribution to managing disease risks effectively."
As rabies in Europe steadily reduces, and with EU harmonised rules continuing to successfully control rabies, Defra says it is monitoring developments in vaccination and disease management in the EU and round the world to ensure that the UK has the most effective and proportionate controls possible as circumstances continue to change.
CEVA Animal Health has added to its joint care range with the launch of Meloxidyl Injection to help control post-operative pain in cats and dogs and alleviate musculoskeletal pain in dogs.
CEVA says Meloxidyl Injection is bioequivalent to the leading meloxicam injection and dogs can be given Meloxidyl oral suspension 24 hours after Meloxidyl Injection has been administered.
Meloxidyl Injection is available in 10ml bottles containing 5mg/ml of meloxicam.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.